Search results
Showing 6706 to 6720 of 7707 results
Vemurafenib for treating resected BRAF V600 mutation-positive melanoma [ID1250]
Discontinued [GID-TA10213]
Apalutamide for treating non-metastatic, hormone-relapsed prostate cancer [ID1174]
Discontinued [GID-TA10377]
Ridaforolimus for the maintenance treatment of metastatic soft tissue or bone sarcoma [ID415]
Discontinued [GID-TAG431]
Nivolumab for previously treated gastric or gastro-oesophageal junction cancer [ID1118]
Discontinued [GID-TA10151]
Pembrolizumab for gastric or gastroesophageal junction adenocarcinoma [ID1305]
Discontinued [GID-TA10244]
Nivolumab with radiation therapy for previously untreated glioblastoma multiforme [ID1562]
Discontinued [GID-TA10443]
Pazopanib for the second line treatment of advanced and/or metastatic renal cell carcinoma [ID70]
Discontinued [GID-TAG398]
Biotin for treating primary and secondary progressive multiple sclerosis [ID919]
Discontinued [GID-TA10099]
Autologous haematopoietic stem cell transplantation for treating multiple sclerosis [ID1111]
Discontinued [GID-TA10306]
Oral paclitaxel with encequidar for treating advanced breast cancer [ID5111]
In development [GID-TA11022] Expected publication date: TBC
The MAGEC system for spinal lengthening in children with scoliosis (MT169)
Discontinued [GID-MT544]
T-cell lymphoma (peripheral, relapsed or refractory) - romidepsin [ID504]
Discontinued [GID-TAG433]
Discontinued [GID-TAG371]
In development [GID-TA10696] Expected publication date: TBC